Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Radius completes $21.4m third financing tranche
The third tranche included $21.4m in equity financing from Radius’ current investors, bringing gross proceeds received to date from the $91m financing to $78.7m. The company intends to
The third tranche included $21.4m in equity financing from Radius’ current investors, bringing gross proceeds received to date from the $91m financing to $78.7m. The company intends to
Both the studies showed that the investigational drug candidate was statistically superior to placebo for all primary and secondary endpoints. Efinaconazole was also found to be generally safe
Metoprolol Succinate Extended-release (ER) Tablets are the generic version of AstraZeneca’s Toprol-XL Tablets, which are indicated for the treatment of hypertension. The launch of the drug is believed
The A0081186 trial is a 12-month randomized double-blind study that enrolled more than 700 patients, who received either a placebo, Lyrica at 300 mg/day, pramipexole at 0.25 mg/day
The move was made following the termination of collaboration between both the companies. AbGn-168H, a humanized monoclonal antibody against CD-162 preferentially induces apoptosis of late-stage activated T-cells and
The platform enhancement also offers the ability of reporting additional ancillary services in the future. The Healthesystems State Reporting Tool has been developed to accommodate the many nuances
Omega-sterol was clinically proven to be effective for blood lipid control and for supporting healthy levels of both blood triglycerides and LDL-cholesterol (bad cholesterol) in humans, the company
The company says the financing proceeds will be used to complete a randomized Phase 2 trial of CRLX101 in non-small cell lung cancer, and to support other investigator-sponsored
The company entered a field-exclusive option agreement with Harvard University to negotiate a license under patent rights that cover prophylactic uses of a modified anthrax toxin protein. The
According to the company, the new protein products offer good taste besides being beneficial for health. The company says that currently there is a need for protein and